Stability Analysis of Microgrid Islanding Transients based on Interconnected Dissipative Subsystems

To ensure successful islanding of microgrids after a fault has occurred, the transient stability should be analyzed under a set of expected operating conditions during the design and operation of microgrids. Transient stability analysis is conventionally performed with time-domain analysis which is computationally expensive and does not quantify the stability margin. Energy-based methodologies can determine the stability margin, however existing methodologies require significant simplifications to be applied to the microgrid model. The energy-based stability analysis methodology proposed in this paper enables the analysis of high-dimension nonlinear microgrid systems and quantification of the stability margin within reasonable time. The performance of the methodology is validated by analyzing a case study microgrid and comparing the results to time-domain analysis and to a state-of-the-art methodology proposed in the literature. The results indicate that the proposed methodology has a significantly lower computational burden and similar accuracy compared to existing energy-based methodologies. The methodology is able to improve the probability of stable islanding of the case study microgrid from 74% up to 94% when only optimizing the design, and up to 100% when optimizing design and control actions

Pretreatment tumor sampling and prognostic factors in patients with soft-tissue sarcoma of the head and neck

Correction: DOI10.1007/s00405-021-07205-6 Early AccessDEC 2021Background Insufficient preoperative work-up and consequent intralesional or marginal resection of soft-tissue sarcomas of the head and neck (STSHNs) is common. Methods This retrospective cohort study comprised 63 patients with STSHN treated at the Helsinki University Hospital between 2005 and 2017. We assessed the effect of pretreatment tumor sampling on surgical margin status and need for supplemental surgery, as well as prognostic factors and survival. Results The lack of representative pretreatment biopsy specimen was associated with unfavorable margin status. Primary surgery at a non-academic center was associated with need for supplemental surgery. The 3-year overall survival (OS) was 68%, disease-specific survival (DSS) 71%, and recurrence-free survival (RFS) 61%. Higher tumor grade and primary tumor size over 5 cm were associated with reduced DSS. Conclusions Diagnosis and management of STSHNs should be centralized to experienced academic centers. Decision-making between needle biopsy, open biopsy, or upfront radical surgery depends on tumor location and size.Peer reviewe

Modelling the two-way coupling of tidal sand waves and benthic organisms:a linear stability approach

We use a linear stability approach to develop a process-based morphodynamic model including a two-way coupling between tidal sand wave dynamics and benthic organisms. With this model we are able to study both the effect of benthic organisms on the hydro- and sediment dynamics, and the effect of spatial and temporal environmental variations on the distribution of these organisms. Specifically, we include two coupling processes: the effect of the biomass of the organisms on the bottom slip parameter, and the effect of shear stress variations on the biological carrying capacity. We discuss the differences and similarities between the methodology used in this work and that from ‘traditional’ (morphodynamics only) stability modelling studies. Here, we end up with a 2×2 linear eigenvalue problem, which leads to two distinct eigenmodes for each topographic wave number. These eigenmodes control the growth and migration properties of both sand waves and benthic organisms (biomass). Apart from hydrodynamic forcing, the biomass also grows autonomously, which results in a changing fastest growing mode (FGM, i.e. the preferred wavelength) over time. As a result, in contrast to ‘traditional’ stability modelling studies, the FGM for a certain model outcome does not necessarily have to be dominant in the field. Therefore, we also analysed the temporal evolution of an initial bed hump (without perturbing biomass) and of an initial biomass hump (without perturbing topography). It turns out that these local disturbances may trigger the combined growth of sand waves and spatially varying biomass patterns. Moreover, the results reveal that the autonomous benthic growth significantly influences the growth rate of sand waves. Finally, we show that biomass maxima tend to concentrate in the region around the trough and lee side slope of sand waves, which corresponds to observations in the field

The chemotherapeutic drug doxorubicin does not exacerbate p16^Ink4a-positive senescent cell accumulation and cardiometabolic disease development in young adult female LDLR-deficient mice

Cancer survivors who received chemotherapy, such as the anthracycline doxorubicin (DOX), have an increased risk of developing complications later in life, including the development of chronic metabolic diseases. Although the etiology of this increased risk for late metabolic complications in cancer survivors is poorly understood, a causal role of therapy-induced senescent cells has been suggested. To study the role of cellular senescence in chemotherapy-induced metabolic complications, young adult female low-density lipoprotein receptor-deficient (Ldlr−/−)-p16-3MR mice, in which p16Ink4a-positive (p16Ink4a+) senescent cells can be genetically eliminated, were treated with four weekly injections of DOX (2.5 mg/kg) followed by a high-fat high-cholesterol diet for 12 weeks. While DOX treatment induced known short-term effects, such as reduction in body weight, gonadal fat mass, and adipose tissue inflammation, it was not associated with significant long-term effects on glucose homeostasis, hepatic steatosis, or atherosclerosis. We further found no evidence of DOX-induced accumulation of p16Ink4a+-senescent cells at 1 or 12 weeks after DOX treatment. Neither did we observe an effect of elimination of p16Ink4a+-senescent cells on the development of diet-induced cardiometabolic complications in DOX-treated mice. Other markers for senescence were generally also not affected except for an increase in p21 and Cxcl10 in gonadal white adipose tissue long-term after DOX treatment. Together, our study does not support a significant role for p16Ink4a+-senescent cells in the development of diet-induced cardiometabolic disease in young adult DOX-treated female Ldlr−/− mice. These findings illustrate the need of further studies to understand the link between cancer therapy and cardiometabolic disease development in cancer survivors.</p

Diagnostic performance of 320-slice multidetector computed tomography coronary angiography in patients after coronary artery bypass grafting

Cardiovascular Aspects of Radiolog

Inhaled sodium cromoglycate for asthma in children

Background Sodium cromoglycate has been recommended as maintenance treatment for childhood asthma for many years. Its use has decreased since 1990, when inhaled corticosteroids became popular, but it is still used in many countries. Objectives To determine the efficacy of sodium cromoglycate compared to placebo in the prophylactic treatment of children with asthma. Search strategy We searched the Cochrane Airways Group Trials Register (October 2007), the Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library Issue 3, 2007), MEDLINE (January 1966 to November 2007), EMBASE (January 1985 to November 2007) and reference lists of articles. We also contacted the pharmaceutical company manufacturing sodium cromoglycate. In 2007 we updated the review. Selection criteria All double-blind, placebo-controlled randomised trials, which addressed the effectiveness of inhaled sodium cromoglycate as maintenance therapy, studying children aged 0 up to 18 years with asthma. Data collection and analysis Two authors independently assessed trial quality and extracted data. We pooled study results. Main results Of 3500 titles retrieved from the literature, 24 papers reporting on 23 studies could be included in the review. The studies were published between 1970 and 1997 and together included 1026 participants. Most were cross-over studies. Few studies provided sufficient information to judge the concealment of allocation. Four studies provided results for the percentage of symptom-free days. Pooling the results did not reveal a statistically significant difference between sodium cromoglycate and placebo. For the other pooled outcomes, most of the symptom-related outcomes and bronchodilator use showed statistically significant results, but treatment effects were small. Considering the confidence intervals of the outcome measures, a clinically relevant effect of sodium cromoglycate cannot be excluded. The funnel plot showed an under-representation of small studies with negative results, suggesting publication bias. Authors' conclusions There is insufficient evidence to be sure about the efficacy of sodium cromoglycate over placebo. Publication bias is likely to have overestimated the beneficial effects of sodium cromoglycate as maintenance therapy in childhood asthma